179 related articles for article (PubMed ID: 34183538)
1. Advanced glycation endproducts and bone quality: practical implications for people with type 2 diabetes.
Moseley KF; Du Z; Sacher SE; Ferguson VL; Donnelly E
Curr Opin Endocrinol Diabetes Obes; 2021 Aug; 28(4):360-370. PubMed ID: 34183538
[TBL] [Abstract][Full Text] [Related]
2. Role of advanced glycation endproducts in bone fragility in type 1 diabetes.
Rubin MR; Dhaliwal R
Bone; 2024 Jan; 178():116928. PubMed ID: 37802378
[TBL] [Abstract][Full Text] [Related]
3. Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes.
Furst JR; Bandeira LC; Fan WW; Agarwal S; Nishiyama KK; McMahon DJ; Dworakowski E; Jiang H; Silverberg SJ; Rubin MR
J Clin Endocrinol Metab; 2016 Jun; 101(6):2502-10. PubMed ID: 27115060
[TBL] [Abstract][Full Text] [Related]
4. Skeletal fragility in diabetes.
Rubin MR
Ann N Y Acad Sci; 2017 Aug; 1402(1):18-30. PubMed ID: 28926113
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes mellitus and bone.
Compston J
J Intern Med; 2018 Feb; 283(2):140-153. PubMed ID: 29265670
[TBL] [Abstract][Full Text] [Related]
6. Contributors to impaired bone health in type 2 diabetes.
Sheu A; Greenfield JR; White CP; Center JR
Trends Endocrinol Metab; 2023 Jan; 34(1):34-48. PubMed ID: 36435679
[TBL] [Abstract][Full Text] [Related]
7. Changes in the Fracture Resistance of Bone with the Progression of Type 2 Diabetes in the ZDSD Rat.
Creecy A; Uppuganti S; Merkel AR; O'Neal D; Makowski AJ; Granke M; Voziyan P; Nyman JS
Calcif Tissue Int; 2016 Sep; 99(3):289-301. PubMed ID: 27209312
[TBL] [Abstract][Full Text] [Related]
8. Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes.
Karim L; Moulton J; Van Vliet M; Velie K; Robbins A; Malekipour F; Abdeen A; Ayres D; Bouxsein ML
Bone; 2018 Sep; 114():32-39. PubMed ID: 29857063
[TBL] [Abstract][Full Text] [Related]
9. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.
Karim L; Bouxsein ML
Bone; 2016 Jan; 82():21-7. PubMed ID: 26211993
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and fractures: an overshadowed association.
Khazai NB; Beck GR; Umpierrez GE
Curr Opin Endocrinol Diabetes Obes; 2009 Dec; 16(6):435-45. PubMed ID: 19779334
[TBL] [Abstract][Full Text] [Related]
11. Effects of Diabetes on Bone Material Properties.
Lekkala S; Taylor EA; Hunt HB; Donnelly E
Curr Osteoporos Rep; 2019 Dec; 17(6):455-464. PubMed ID: 31713179
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes and bone fractures.
Moseley KF
Curr Opin Endocrinol Diabetes Obes; 2012 Apr; 19(2):128-35. PubMed ID: 22262002
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of diabetes mellitus-induced bone fragility.
Napoli N; Chandran M; Pierroz DD; Abrahamsen B; Schwartz AV; Ferrari SL;
Nat Rev Endocrinol; 2017 Apr; 13(4):208-219. PubMed ID: 27658727
[TBL] [Abstract][Full Text] [Related]
14. The impact of advanced glycation end products on bone properties in chronic kidney disease.
Damrath JG; Creecy A; Wallace JM; Moe SM
Curr Opin Nephrol Hypertens; 2021 Jul; 30(4):411-417. PubMed ID: 33928911
[TBL] [Abstract][Full Text] [Related]
15. Induction and rescue of skeletal fragility in a high-fat diet mouse model of type 2 diabetes: An in vivo and in vitro approach.
LLabre JE; Sroga GE; Tice MJL; Vashishth D
Bone; 2022 Mar; 156():116302. PubMed ID: 34952229
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Type 2 Diabetes on Bone Biomechanics.
Karim L; Rezaee T; Vaidya R
Curr Osteoporos Rep; 2019 Oct; 17(5):291-300. PubMed ID: 31392668
[TBL] [Abstract][Full Text] [Related]
17. The role of advanced glycation end products in fracture risk assessment in postmenopausal type 2 diabetic patients.
Gao L; Liu C; Hu P; Wang N; Bao X; Wang B; Wang K; Li Y; Xue P
Front Endocrinol (Lausanne); 2022; 13():1013397. PubMed ID: 36578954
[TBL] [Abstract][Full Text] [Related]
18. Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men.
Lamb LS; Alfonso H; Norman PE; Davis TME; Forbes J; Müench G; Irrgang F; Almeida OP; Golledge J; Hankey GJ; Flicker L; Yeap BB
J Clin Endocrinol Metab; 2018 Nov; 103(11):4224-4231. PubMed ID: 30137355
[TBL] [Abstract][Full Text] [Related]
19. Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength.
Leanza G; Cannata F; Faraj M; Pedone C; Viola V; Tramontana F; Pellegrini N; Vadalà G; Piccoli A; Strollo R; Zalfa F; Beeve AT; Scheller EL; Tang SY; Civitelli R; Maccarrone M; Papalia R; Napoli N
Elife; 2024 Apr; 12():. PubMed ID: 38598270
[TBL] [Abstract][Full Text] [Related]
20. Diabetes, collagen, and bone quality.
Saito M; Kida Y; Kato S; Marumo K
Curr Osteoporos Rep; 2014 Jun; 12(2):181-8. PubMed ID: 24623537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
